Related Experiment Videos
Structure of a pertussis toxin-sugar complex as a model for receptor binding
P E Stein1, A Boodhoo, G D Armstrong
1Department of Medical Microbiology and Infectious Diseases, University of Alberta, Edmonton, Canada.
Nature Structural Biology
|September 1, 1994
Summary
Pertussis toxin, crucial for whooping cough pathogenesis, binds to host cells via carbohydrate receptors. This study reveals the toxin's specific binding sites, aiding in developing improved acellular vaccines.
Area of Science:
- Microbiology
- Structural Biology
- Immunology
Background:
- Pertussis toxin is an exotoxin produced by *Bordetella pertussis*, the causative agent of whooping cough.
- The toxin plays a key role in both disease pathogenesis and the induction of protective immunity.
- Its biological activities are mediated by interactions with carbohydrate-containing receptors on eukaryotic cells.
Purpose of the Study:
- To elucidate the structural basis of pertussis toxin's interaction with host cell receptors.
- To identify specific binding sites involved in toxin-receptor recognition.
- To inform the design of novel acellular whooping cough vaccines.
Main Methods:
- X-ray crystallography was employed to determine the structure of pertussis toxin.
- The toxin was co-crystallized with a soluble oligosaccharide derived from transferrin.
- Analysis of the complex structure identified key amino acid residues and carbohydrate moieties involved in binding.
Main Results:
- The crystal structure of pertussis toxin complexed with a transferrin-derived oligosaccharide was determined.
- Specific binding sites for the terminal sialic acid-galactose moiety were identified on the S2 and S3 subunits of the toxin's B-oligomer.
- Key amino acid residues mediating these interactions were revealed.
Conclusions:
- The study provides a detailed structural understanding of pertussis toxin's carbohydrate recognition mechanism.
- Identification of receptor-binding sites facilitates the rational design of modified toxins.
- This knowledge is critical for developing next-generation acellular pertussis vaccines with enhanced efficacy and safety.